Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Viome · with New York Medical College · NCT05451303
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 475
- US sites recruiting
- 1
- Study start
- May 27, 2022
- Record last updated
- January 29, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
To evaluate the design, safety and efficacy of OralViome Cancer Testing system in the early detection of Oral and Throat Cancers using saliva metatranscriptomic analysis. This study will recruit only at existing clinical sites and will NOT use any additional clinical sites.
Being studied: OralViome Cancer Testing System
Conditions: Oral Squamous Cell Carcinoma; Oropharynx Squamous Cell Carcinoma; Premalignant Lesion
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Signed Informed Consent obtained
- 18 years and older
- At a high risk of developing oral or throat cancer based on clinician's discretion
Exclusion Criteria
- Pregnancy
- Use of fertility enhancing medications
Recruiting US locations
NYMC
New York, NY 10595
Site contact: Mohanapriya Rajamoorthy · (914) 594-4575
Study contacts (from the official record)
- Mory Mehrtash, MSc · 425-300-6933 · studies@viome.com
- Momchilo Vuyisich, PhD · 425-300-6933 · studies@viome.com
Similar studies in New York
All smoking & vaping studies in New York →- RecruitingHealthy volunteersEarly Phase 1
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
Roswell Park Cancer Institute
- Location
- Buffalo, NY
- Eligibility basics
- Ages 21+
- RecruitingPhase 3
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Axsome Therapeutics, Inc.
- Location
- Brooklyn, NY + 24 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Eli Lilly and Company
- Location
- Rochester, NY + 16 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
The CONQUER Trial - Cessation Of Nicotine, QUitting With E-cigarette Reduction
VapeAway
- Location
- New York, NY
- Eligibility basics
- Ages 21+